Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers

BACKGROUND: The rational use of antibiotics is one of the main strategies to limit the development of bacterial resistance. We therefore sought to evaluate the effectiveness of a C-reactive protein-based protocol in reducing antibiotic treatment time in critically ill patients. METHODS: A randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Isabela, Carneiro, Rafael, Bergo, Rafael, Martins, Larissa, Colosimo, Enrico, Oliveira, Carolina, Saturnino, Saulo, Andrade, Marcus Vinícius, Ravetti, Cecilia, Nobre, Vandack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266125/
https://www.ncbi.nlm.nih.gov/pubmed/32487263
http://dx.doi.org/10.1186/s13054-020-02946-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266125/
https://www.ncbi.nlm.nih.gov/pubmed/32487263
http://dx.doi.org/10.1186/s13054-020-02946-y

Ejemplares similares